In December 2025, FDA issued a Warning Letter to Darmerica , an Active Pharmaceutical Ingredient (API) importer/manufacturer citing cGMP violations, distribution of retatrutide to 503A compounding pharmacies, and failure to list all drugs distributed into interstate commerce in violation of section 510(j) of the FD&C Act
When the body is purified, good skin also becomes more radiant, less common problems such as acne, darkening the skin or irritation
At Bonakdar Aesthetics, our boutique med spa in Newport Beach, our physician-led program uses GLP-1 and dual GLP-1/GIP injections to support sustainable weight loss with clear dosing, steady follow-up, and a plan that fits real life in Orange County
Timing the Introduction of AOD-9604 The question of when to add AOD-9604 to your Retatrutide protocol matters
& Tavakoli, M